Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06147856
Status:
WITHDRAWN
Last Update Posted:
2024-05-14
First Post:
2023-11-18
Brief Title:
A Dose-finding Study to Evaluate mRNA-3210 in Participants With Phenylketonuria
Sponsor:
ModernaTX Inc
Organization:
ModernaTX Inc
Study Overview
Official Title:
A Phase 12 First-in-Human Open-Label Dose Escalation Study to Assess the Safety Tolerability Pharmacokinetics and Pharmacodynamics of mRNA 3210 in Participants With Phenylketonuria
Status:
WITHDRAWN
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The Sponsor no longer intends to recruit to this study
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main goal of this study is to assess the safety and tolerability of multiple doses of mRNA-3210 in participants with phenylketonuria PKU
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2023-506963-32-00 | OTHER | EU-CT Number | None |